| abstract |
The present invention relates to a composition suitable for oral administration comprising: a) itraconazole or saperkonazole as an antifungal agent, b) hydroxypropyl-cyclodextrin sufficient to dissolve the active ingredient, having an MS value of 0.3-3.0 and less than 5% (c) an aqueous acidic medium as a liquid carrier; (d) 1 to 20% by volume of alcohol-co-solvent, which is ethanol, propylene glycol or glycerin; (e) a less pharmaceutically acceptable bulk sweetener ("bulk sweetener"); ), and f) one or more pharmacologically acceptable flavors |